Entocort EC, a new ORAL form of budesonide for Crohn's disease

AstraZeneca will soon introduce Entocort EC, a new ORAL form of budesonide for Crohn's disease.

It's approved for acute flare-ups that involve the ileum and/or ascending colon...it's not approved for chronic use.

Entocort EC releases budesonide in the small intestine and colon to decrease inflammation.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote